Abstract:Background: Odd-skipped related 1 (OSR1) has been reported as a tumor suppressor gene in various malignant tumors. The mechanism through which OSR1 regulates ovarian cancer (OC) progression remains unclear. Materials and methods: Immunohistochemistry was utilized to evaluate OSR1 expression in patients with ovarian cancer. We investigated the association between clinicopathological parameters and OSR1 expression in OC patients and the influence of OSR1 expression on patient survival and prognosis. OC cells with OSR1 overexpression or knockdown were established and validated using Western blot and Quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The influence of OSR1 on the NF-κB pathway was examined by analyzing the p-IκBα, IκBα, p65, and p-p65 protein expression. In vitro assays, such as cell cycle assay, Cell Counting Kit-8 (CCK-8), transwell invasion assay, wound healing migration assay, enzyme-linked immunoassay (ELISA), and Annexin V/PI flow cytometry apoptosis assay, were conducted to explore the effect of OSR1 knockdown or dual inhibition of OSR1 and the NF-κB pathway on OC malignant biological behavior. Results: OSR1 expression was downregulated in OC tissues, with significant associations observed between its expression and The International Federation of Gynecology and Obstetrics (FIGO) stage and tissue differentiation. Low OSR1 expression in OC patients correlated with reduced overall survival (OS) rates and poor prognosis. In vitro, experiments confirmed a negative correlation between OSR1 expression and NF-κB pathway activity. OSR1 knockdown facilitated OC cell malignant biological behavior, while the NF-κB pathway inhibitor (Bay 11-0782) reversed the impacts of OSR1 knockdown on cell proliferation, migration, invasion, and apoptosis. Conclusion: Our findings indicate that OSR1 is downregulated and associated with OC prognosis. OSR1 suppresses NF-κB pathway activity and inhibits OC progression by targeting the NF-κB pathway.

Expression of NOB1 Gene and Its Clinical Significance in Ovarian Cancer

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

Expression of the NOB1 Gene and Its Clinical Significance in Papillary Thyroid Carcinoma

EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.

Prognostic Value of NOB1 Expression Levels in Various Cancers: a Systematic Review and Meta-Analysis.

Clinical Significance of Nob1 Expression in Breast Infiltrating Ductal Carcinoma

RNAi-mediated Downregulation of NOB1 Suppresses the Growth and Colony-Formation Ability of Human Ovarian Cancer Cells

NOB1 Gene As a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.

Relationship between expression of CXCL1 mRNA in ovarian tumor tissues and clinical-pathology factors

Positive Nin One Binding Protein Expression Predicts Poor Outcome in Prostate Cancer.

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer

[Expression and Clinical Significance of DNAJB11 in Epithelial Ovarian Cancer].

Expression of Nucleostemin Gene in Epithelial Ovarian Tumor and Its Relation with Clinical Pathology

Clinicopathological Significance and Underlying Molecular Mechanism of Downregulation of Basonuclin 1 Expression in Ovarian Carcinoma.

Clinical Significance Of Ngal And Mmp-9 Protein Expression In Epithelial Ovarian Cancers

ROR1 Expression Correlated with Poor Clinical Outcome in Human Ovarian Cancer

MicroRNA-363 Inhibits Ovarian Cancer Progression by Inhibiting NOB1.

Lentivirus-Mediated Knockdown of NOB1 Suppresses the Proliferation of Colon Cancer Cells

Notch1 expression correlates with tumor differentiation status in ovarian carcinoma

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.

The role of nucleolar spindle‐associated protein 1 in human ovarian cancer